venBio Select Advisor as of June 30, 2017
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 43 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 11.5 | $93M | 11M | 8.83 | |
| Kite Pharma | 10.4 | $84M | 807k | 103.67 | |
| Amicus Therapeutics (FOLD) | 7.7 | $62M | 6.2M | 10.07 | |
| Tesaro | 7.0 | $56M | 400k | 139.86 | |
| Medicines Company | 6.2 | $50M | 1.3M | 38.01 | |
| BioMarin Pharmaceutical (BMRN) | 5.7 | $46M | 501k | 90.82 | |
| Array BioPharma | 4.9 | $39M | 4.7M | 8.37 | |
| Dermira | 4.8 | $39M | 1.3M | 29.14 | |
| Teligent | 4.7 | $38M | 4.1M | 9.15 | |
| Iovance Biotherapeutics (IOVA) | 3.8 | $31M | 4.2M | 7.35 | |
| Ascendis Pharma A S (ASND) | 3.4 | $28M | 991k | 27.76 | |
| Global Blood Therapeutics In | 2.9 | $24M | 860k | 27.35 | |
| Pacira Pharmaceuticals (PCRX) | 2.8 | $22M | 466k | 47.70 | |
| ACADIA Pharmaceuticals (ACAD) | 2.1 | $17M | 614k | 27.89 | |
| Vanda Pharmaceuticals (VNDA) | 1.8 | $15M | 902k | 16.30 | |
| AVEO Pharmaceuticals | 1.8 | $15M | 6.6M | 2.22 | |
| Clovis Oncology | 1.6 | $13M | 141k | 93.63 | |
| Assembly Biosciences | 1.6 | $13M | 607k | 20.65 | |
| Agenus | 1.6 | $12M | 3.2M | 3.91 | |
| Aerie Pharmaceuticals | 1.5 | $12M | 231k | 52.55 | |
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $11M | 2.0M | 5.56 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.3 | $11M | 3.8M | 2.76 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $10M | 220k | 46.00 | |
| Mirati Therapeutics | 1.0 | $8.3M | 2.3M | 3.65 | |
| Alimera Sciences | 1.0 | $8.2M | 5.9M | 1.39 | |
| Veracyte (VCYT) | 0.9 | $7.6M | 908k | 8.33 | |
| Sangamo Biosciences (SGMO) | 0.9 | $7.0M | 800k | 8.80 | |
| Cascadian Therapeutics | 0.8 | $6.8M | 1.8M | 3.72 | |
| Viveve Med | 0.7 | $5.7M | 796k | 7.18 | |
| Argenx Se (ARGX) | 0.6 | $4.6M | 216k | 21.21 | |
| Nevro (NVRO) | 0.5 | $3.7M | 50k | 74.44 | |
| Fortress Biotech | 0.4 | $2.9M | 604k | 4.75 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $2.2M | 120k | 18.33 | |
| Cellectis S A (CLLS) | 0.3 | $2.2M | 86k | 25.81 | |
| Axovant Sciences | 0.2 | $1.9M | 82k | 23.19 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.9M | 6.0M | 0.31 | |
| Spdr S&p 500 Etf Tr option | 0.2 | $1.5M | 250k | 5.82 | |
| Neuroderm Ltd F | 0.2 | $1.3M | 45k | 29.90 | |
| Sorrento Therapeutics (SRNE) | 0.1 | $833k | 416k | 2.00 | |
| Oncobiologics | 0.1 | $684k | 684k | 1.00 | |
| Ovascience | 0.1 | $489k | 313k | 1.56 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $40k | 233k | 0.17 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $21k | 233k | 0.09 |
